Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


B&L Pledges Commitment To Product Pipeline Despite R&D Cuts

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb remains dedicated to its R&D pipeline despite cutting its funding forecast for the remainder of the year, the company maintained during a third-quarter earnings call Oct. 19

You may also be interested in...

Pharma Firms Ready To Repatriate Billions Once “JOBS” Bill Is Signed

J&J intends to repatriate as much as $10 bil. held by foreign subsidiaries following President Bush's expected signing of the "JOBS" bill

Bausch & Lomb Looks To Vitamin Extension To Sustain Double-Digit Growth

Bausch & Lomb plans to launch a line extension and new formulation for its Ocuvite PreserVision vitamin brand this quarter

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts